【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Otitis Media Overview 8
Therapeutics Development 9
Pipeline Products for Otitis Media – Overview 9
Pipeline Products for Otitis Media – Comparative Analysis 10
Otitis Media – Therapeutics under Development by Companies 11
Otitis Media – Therapeutics under Investigation by Universities/Institutes 13
Otitis Media – Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Otitis Media – Products under Development by Companies 17
Otitis Media – Products under Investigation by Universities/Institutes 18
Otitis Media – Companies Involved in Therapeutics Development 19
Arbor Pharmaceuticals, LLC. 19
BCO Pharma Ltd 20
Cellceutix Corporation 21
ContraFect Corporation 22
Cubist Pharmaceuticals, Inc. 23
GlaxoSmithKline plc 24
Laboratorios SALVAT S.A. 25
Otonomy, Inc. 26
Serum Institute of India Limited 27
Yuhan Corporation 28
Otitis Media – Therapeutics Assessment 29
Assessment by Monotherapy Products 29
Assessment by Combination Products 30
Assessment by Target 31
Assessment by Mechanism of Action 33
Assessment by Route of Administration 35
Assessment by Molecule Type 37
Drug Profiles 39
(fluocinolone acetonide + ciprofloxacin hydrochloride) – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
AR-01 – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
BCO-002 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
betahistine hydrochloride – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
brilacidin – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
CF-309 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
ciprofloxacin SR – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
GSK-2189242A – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
P-13 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Recombinant Peptide to Inhibit DNA for Otitis Media and Haemophilus Influenzae Infections – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
SIILPCV-10 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
solithromycin – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
YH-1177 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Otitis Media – Recent Pipeline Updates 55
Otitis Media – Dormant Projects 72
Otitis Media – Product Development Milestones 73
Featured News & Press Releases 73
Sep 29, 2014: SALVAT announces positive top-line results from two Phase III studies of its novel otic antibiotic/steroid combination solution in the treatment of AOMT with Tympanostomy tubes 73
Jul 08, 2014: Otonomy Announces Positive Results from Two Phase 3 Trials of AuriPro in Pediatric Patients Undergoing Ear Tube Placement Surgery 74
May 08, 2014: Otonomy Completes Enrollment of AuriPro Pivotal Studies in Pediatric Patients Undergoing Ear Tube Placement Surgery 74
Feb 24, 2014: Cellceutix Selects Dr. Reddy’s Laboratories for Formulation of Brilacidin for Ophthalmic and Otitis Infections 75
Dec 11, 2013: Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery 76
Aug 20, 2013: Otonomy Announces Positive Phase 1b Results for OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery 76
May 28, 2013: Salvat Completes Enrollment Of Phase III Study For New Combination In Acute Otitis Media In Pediatric Patients With Tympanostomy Tubes 77
Oct 29, 2012: Study Suggests New Way to Prevent Recurrent Ear Infections 78
Jun 08, 2011: Otonomy Announces Positive Preclinical Results For OTO-201 79
Dec 30, 2010: 13therapeutics Completes Pre-IND Meeting With FDA 80
Appendix 81
Methodology 81
Coverage 81
Secondary Research 81
Primary Research 81
Expert Panel Validation 81
Contact Us 82
Disclaimer 82
【レポート販売概要】
■ タイトル：中耳炎(Otitis Media)の治療薬パイプライン動向（2015年上半期版）■ 英文：Otitis Media - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6068IDB
■ 調査対象地域：グローバル
- 世界の消化性潰瘍治療薬市場（2014-2018）About Peptic Ulcer and Drugs Used for the Treatment A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life- …
- 協働ロボットの世界市場2017-202：マテリアルハンドリング、一般アセンブリ、塗装、検査、溶接、機械管理、パッケージング、パレタイジングAbout Collaborative Robots At present, collaborative robots are being increasingly adopted by automotive, electrical and electronics and semiconductors, rubber and plastic, and metal processing. Concerns over a slowdown in economic growth of major countries such as China, the US, and Japan and the availability of safety systems in traditional industrial robots are likely to hinder the market growt …
- 福祉ロボットの世界市場：義肢ロボット、装具ロボット、セラピー用ロボット、外骨格ロボットAbout Rehabilitation Robotics Rehabilitation robots play an important role in improving a patient’s functional recovery. Stroke is a global problem, and it is the main cause of disability in most western countries. Rehabilitation robots are used as therapy aids and the potential benefit of robotic therapy is that it can treat a larger number of patients under the supervision of a single therapist. …
- IoTチップの世界市場予測（～2022）：ハードウェア別（プロセッサ、センサー、接続IC、メモリー機器、ロジック機器）、最終用途別（ウェアラブル機器、ビルディングオートメーション、産業、自動車・輸送、その他）、地域別“IoT chip market expected to grow at a CAGR of 13.2% during the forecast period”The IoT chip market is expected to be valued at USD 14.81 billion by 2022, growing at a CAGR of 13.2% from 2016 to 2022. The growth of the IoT chip market can be attributed to the growing market of connected devices as well as increasing investments in the IoT industry. However, the lack of common communication protoco …
- Wintershall Holding GmbH：石油・ガスの開発・生産動向及びコスト分析- 2012Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 皮下投与（ドラッグデリバリー）の世界市場及びパイプライン分析Subcutaneous sites along with intramuscular and intravenous sites are part of parenteral route of drug entry. Maximum pharmacological benefits of a drug could be achieved by deciding effective route of administration depending upon pharmacodynamic properties of the drug to be used. Subcutaneous route is commonly used for the administration of therapeutics into the body for better drug delivery of …
- 薬用飼料添加剤の世界市場2016-2020About Medicinal Feed Additives Medicinal feed additives contain veterinary medicines and other nutritive supplements and are added to animal feed. Consumers and animal farmers use these products as an effective way to administer medicines to animals. These products comprise of essential vitamins, minerals, trace elements, anti-oxidants, antibiotics, vaccines, preservatives, and other related ingre …
- 高温耐熱性接着剤の世界市場：エポキシ接着剤、シリコン接着剤、アクリル接着剤、ポリウレタン接着剤The high temperature adhesives market size in terms of value is projected to grow at a CAGR of 4.6% between 2014 and 2019 to reach $4.02 billion by 2019. Asia-Pacific held the largest share in high temperature adhesives market in 2013. Major growth in the Asia-Pacific region is expected from the growing automotive and electronics application. The high temperature adhesives market in Asia-Pacific r …
- 肺炎球菌性髄膜炎(Pneumococcal Meningitis)：世界の治験レビュー2014年下半期版Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Pneumococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pneumococcal Meningitis. It includes an overview of the trial numbers …
- Ultra Petroleum Corp.社の石油・ガス開発・生産動向及びコスト分析（2013年）Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 積層セラミックコンデンサ（MLCC）の世界市場2016-2020About the Multi-Layer Ceramic Capacitor (MLCC) Market An MLCC is a monolithic device with laminated layers of ceramic dielectric materials, scattered with the metal electrode system. The layers are exposed to high temperature to make a sintered and efficient capacitance device. A conducive barrier system is integrated with the exposed ends of the chip to complete the linking. MLCCs are categorized …
- 乾癬市場：アメリカの治療薬市場Psoriasis - US Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for pati …
- 低侵襲性手術機器の世界市場：手持ち器具、ガイド装置、拡張装置、切断装置The minimally invasive surgical instruments market is projected to reach USD 18.14 Billion by 2021 from USD 11.16 Billion in 2016, at a CAGR of 10.2%. Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements …
- 心臓バイオマーカーの世界市場分析：タイプ別（トロンポニン、クレアチンキナーゼ-MB（CK-MB）、ナトリウム利尿ペプチド-B型ナトリウム利尿ペプチド（BNP）･N末端プロb型ナトリウム利尿ペプチド（NT-proBNP）、ミオグロビン、虚血修飾アルブミン（IMA）、心臓型脂肪酸結合タンパク質（H-FABP）、LDHアイソザイム）、用途別（急性冠動脈症候群、心筋梗塞、うっ血性心不全、心筋症、虚血、心筋炎、心房細動）、エンドユーザー別、地域別、セグメント予測The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease d …
- マレーシアの原油精製市場（～2021）Malaysia Crude Oil Refinery Outlook to 2021 Summary "Malaysia Crude Oil Refinery Outlook to 2021" is a comprehensive report on crude oil refinery industry in Malaysia. The report provides oil production, consumption, exports and imports details from 2000 to 2020 along with oil reserves for the period 2000 to 2015. The report also provides details on oil refineries such as name, type, operational s …
